Sun Pharma Advanced Research Company LtdPharmaceuticalsINE232I01014Consolidated₹185.33+9.59 (+5.46%)
Valuation
Market Cap₹6.01K Cr
TTM PE3.68x
Forward PE2.63x
PEG1.13
Book Value₹44.44
P/B4.17x
TTM EPS₹50.40
Fwd EPS₹70.51
TTM Revenue₹1.93K Cr
TTM PAT₹1.64K Cr
TTM EBITDA₹1.64K Cr
TTM EBIT₹1.63K Cr
Last Qtr PAT₹-24.39 Cr
Last Qtr EBITDA₹-45.61 Cr
Last Qtr EBIT₹-47.81 Cr
Profitability
ROE113.43%
ROCE120.78%
TTM NPM84.68%
TTM EBITDA %84.74%
Curr OPM-45.46%
Last OPM-32.68%
Curr NPM—
Last NPM—
Curr EPS₹-0.75
Last EPS₹-0.64
Balance sheet
Equity₹32.45 Cr
Reserve₹1.41K Cr
Total Debt₹2.44 Cr
D/E0.00x
Interest %-0.49%
Curr Interest₹0.12 Cr
Price / range
Close₹185.33
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+5.46%
1W+1.46%
1M-4.53%
3M-10.59%
6M+32.66%
1Y+35.48%
2Y-9.64%
3Y-22.68%
5Y-31.28%
Diwali+37.28%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue30.03+282.1%39.921,853.228.457.861,879.17
Other Income23.6223.661.8000.0110.83
Total Income53.65+581.7%63.581,855.028.457.871,890
Interest0.128.1311.648.787.5234.12
Expenditure-78.23+6.7%-84.56-94.32-76.66-83.84-325.51
PBDT000000
EBITDA-45.88+30.4%-34.311,772.94-56.87-65.891,597.85
Depreciation-2.20-2.20-2.40-2.56-2.57-10.07
EBIT-48.08+29.8%-36.511,770.54-59.43-68.461,587.78
PBT-24.58+67.6%-20.981,760.70-80.57-75.971,552.13
Tax000000
Equity32.4532.4532.4532.45032.45
OPM-45.82-33.0094.92-953.49-966.5482.12
Net Profit-24.58+67.6%-20.981,760.70-80.57-75.971,552.13
NPM-45.82-33.0094.92-953.49-966.5482.12
EPS-0.76+67.5%-0.6554.26-2.48-2.3447.83

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue1,879.17+2518.3%71.77-5.0%75.55-68.4%238.78+74.0%137.25-45.7%252.96
Other Income10.831.7929.4710.886.845.41
Total Income1,890+2469.3%73.56-30.0%105.02-57.9%249.66+73.3%144.09-44.2%258.37
Expenditure-325.51+22.3%-418.78+15.1%-493.13-4.4%-472.24-35.9%-347.49+15.1%-409.51
Interest-34.12-8.91-1.66-7.63-13.33-10.65
PBDT000000
EBITDA1,597.85+588.2%-327.27+19.0%-403.79-88.6%-214.06-14.6%-186.75-38.4%-134.98
Depreciation-10.07-10.83-12.13-11.77-10.16-10.92
EBIT1,587.78+569.6%-338.10+18.7%-415.92-84.2%-225.83-14.7%-196.91-35.0%-145.90
PBT1,552.13+549.6%-345.22+11.1%-388.11-74.4%-222.58-9.4%-203.40-34.6%-151.14
Tax000000
Equity32.4532.450000
OPM (%)82.12-469.30-370.00-89.00-141.00-58.00
Net Profit1,552.13+549.6%-345.22+11.1%-388.11-74.4%-222.58-9.4%-203.40-34.6%-151.14
NPM (%)82.12-469.30-370.00-89.00-141.00-58.00
EPS (Rs)47.830+100.0%-11.96-52.9%-7.82-1.2%-7.73-34.0%-5.77
CEPS47.830-11.96-7.827.73-5.77

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue30.03+282.1%39.921,853.228.457.861,879.17
Other Income23.6223.661.8000.0110.95
Total Income53.65+581.7%63.581,855.028.457.871,890.12
Interest0.128.1311.648.787.5234.13
Expenditure-77.96+6.8%-84.25-94.06-76.44-83.66-324.75
PBDT000000
EBITDA-45.61+30.6%-341,773.20-56.64-65.721,598.76
Depreciation-2.20-2.20-2.40-2.57-2.56-10.21
EBIT-47.81+30.0%-36.201,770.80-59.21-68.281,588.55
PBT-24.31-20.671,760.96001,553.01
Tax-0.08-0.110.38-0.07-0.060.19
Equity32.4532.4532.450032.45
OPM-45.31-32.5194.930.000.0082.16
Net Profit-24.39+67.8%-20.781,761.34-80.42-75.851,553.20
NPM-45.46-32.6894.95-951.72-963.7982.17
EPS-0.75+67.9%-0.6454.27-2.48-2.3447.86

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 3 years
MetricFY 25-26FY 24-25FY 23-24
Revenue1,879.17+2518.3%71.77-5.0%75.55
Other Income10.951.7929.47
Total Income1,890.12+2469.5%73.56-30.0%105.02
Expenditure-324.75+22.0%-416.34+15.4%-491.85
Interest-34.13-9.04-1.69
PBDT000
EBITDA1,598.76+594.8%-323.14+19.6%-402.10
Depreciation-10.21-12.39-12.51
EBIT1,588.55+573.4%-335.53+19.1%-414.61
PBT1,553.01+553.1%-342.78+11.4%-386.83
Tax0.190.27-0.38
Equity32.4532.450
OPM (%)82.16-465.99-368.34
Net Profit1,553.20+553.5%-342.51+11.5%-387.21
NPM (%)82.17-465.62-368.70
EPS (Rs)47.860+100.0%-11.93
CEPS00-11.93

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

0

No dividend history.

Bonus

0

No bonus history.

Split

0

No split history.

Loading company dashboard...
Fetching ratios, charts, and peers